Western Australian Consolidated Regulations (1) Subject to
subregulations (2) and (3), a substance included in Schedule 3 shall
not be advertised except in a bona fide professional or trade journal or other
publication intended for circulation only within the medical, veterinary,
dental or pharmaceutical professions or the wholesale and manufacturing drug
trade.
(2) A substance both
included in Schedule 3 and listed in Appendix H of SUSDP may be
advertised by its brand name or its approved name.
(3) A substance
included in Schedule 3 may be advertised if the substance is in a
pregnancy testing kit.
(4) In this
regulation —
approved name , in relation to a poison, means the
name for the poison that is listed in the Australian Register of Therapeutic
Goods, other than a brand name of the poison;
Australian Register of Therapeutic Goods means the
register of that name maintained under section 17 of the Therapeutic
Goods Act 1989 of the Commonwealth;
brand name , in relation to a poison, means a name
given to the poison by a manufacturer of it and listed in the Australian
Register of Therapeutic Goods, other than its approved name.
[Regulation 35C inserted in Gazette
23 Sep 1983 p. 3803; amended in Gazette 2 Oct 1987
p. 3776; 19 Mar 1996 p. 1221; 27 Nov 1998
p. 6343-4.]